OBJECTIVE The aetiopathogenesis of the primary systemic vasculitides (PSV) is unknown but includes both environmental and genetic factors. The development of classification criteria/definitions for PSV allows comparison of the epidemiology between different regions.
METHODS The same methods and the American College of Rheumatology (1990) criteria or Chapel Hill definitions were used to compare the epidemiology of Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, and polyarteritis nodosa in Norwich (east England population 413 500) and Lugo (northwest Spain population 204 100). Patients with PSV were identified between 1 January 1988 and 31 December 1998.
RESULTS Overall, the incidence of PSV in adults was almost equal in Norwich (18.9/million) and Spain (18.3/million). The incidence of Wegener's granulomatosis in Norwich (10.6/million) was greater than in Spain (4.9/million). There was a marked age-specific increase in incidence in Norwich with a peak age 65–74 years (52.9/million), but a virtually equal age distribution between ages 45 and 74 in Lugo (34.1/million). There was no significant increase with time in either population, or evidence of cyclical changes in incidence.
CONCLUSION These data support the suggestion that environmental factors may be important in the pathogenesis of PSV.
Statistics from Altmetric.com
The primary systemic vasculitides (PSV—Wegener's granulomatosis (WG), Churg-Strauss syndrome (CSS), microscopic polyangiitis (MPA), polyarteritis nodosa (PAN)) are a group of rare conditions characterised by inflammation and necrosis of blood vessel walls. The aetiopathogenesis of these conditions is poorly understood, but environmental and genetic factors are important. Clues to environmental factors can be obtained by comparing the incidence in different regions of the world, looking for clusters both in time and space and for associations with infectious disease. Pointers towards a genetic component come from studies of the human leucocyte antigen (HLA) type of patients, familial occurrence, and differences in incidence in various ethnic groups. The recent development of agreed classification criteria and definitions1-4 enables comparison of studies from different groups. Anecdotal evidence suggests that WG is more common in northern Europe, whereas MPA is believed to show the opposite trend. We previously reported data on the epidemiology of PSV in our two populations5 6 using different methods. This study aimed at comparing directly the incidence of PSV over an 11 year period in two different regions of Europe using the same methods and classification criteria.
Patients and methods
The study was hospital based in two regions of Europe—Norwich Health Authority (NHA) Norfolk, UK (latitude 52°N), and Hospital Xeral-Calde, Lugo, Spain (43°N). The NHA provided administrative services to a group of general practices covering a population of 413 500. Patients were included if they were registered with one of these practices. Hospital services were provided by a single institution—Norfolk and Norwich Hospital. In Lugo the Hospital Xeral-Calde is the only referral centre for a population of almost 250 000 people and serves a defined population. The studies were both performed between 1 January 1988 and 31 December 1998. Patients with vasculitis diagnosed before or after the study period were excluded.
The American College of Rheumatology (ACR) criteria for PAN,1 WG,2 and CSS3 were used to classify all patients. The Chapel Hill Consensus Conference (CHCC) definitions were applied to all patients.4 Patients who failed to fulfil any of these criteria were not included, nor were patients with other types of vasculitis.
In 1992 the adult (>15 years) population in Norwich was 413 500 (men 200 000, women 213 500). The population has now increased and in 1997 was 429 000 (men 207 000) owing to slight net immigration. The population turnover is about 3–4% each year. The population includes a higher number of patients who are aged >65 years old (21.5%) compared with the national average for England and Wales (17.8%). The population is 98% Caucasoid, and one third live within 5 km of the city centre. The adult population of Lugo in 1992 was 204 100 (men 99 900, women 104 200). The population fell by 6000 between 1980 and 2000. There is little immigration or emigration. The population contains 21.3% aged >65 years of age. The population is Caucasoid of Celtic origin and 21% live within the city.
Age-specific and sex-specific incidence rates were calculated using the number of incident cases as the numerator and the population as the denominator. Incidence rates were compared for the periods 1988–92 and 1993–98. To investigate whether there were any cyclical peaks a rolling three year centred average was calculated. 95% Confidence intervals (95% CI) were calculated assuming that the number of observed cases followed the Poisson distribution.
A total of 127 patients presented with new onset PSV (86 Norwich, 41 Lugo) in the two populations over an 11 year period. The overall annual incidence of PSV in adults was 18.9/million in Norwich and 18.3/million in Lugo (table 1). There was a greater incidence of WG in Norwich (10.6/million) than in Lugo (4.9/million), whereas MPA was more common in Lugo (table 1). The incidence of PAN and CSS was higher in Norwich. There was no significant change in incidence between 1988–92 and 1993–98 in either Norwich (15.5/million (95% CI 10.6 to 21.9) and 21.0/million (95% CI 15.6 to 27.4)) or Lugo (18.6/million (95% CI 11.2 to 29.1) and 18.0/million (95% CI 11.3 to 27.2). A rolling triennial average did not disclose any cyclical changes in incidence. In Norwich, there was an age-specific increase in incidence peaking in the 65–74 year group; the age distribution was much flatter in Lugo with an almost equal incidence between ages 45 and 74 (fig 1). In Norwich the peak incidence was 52.9/million (35.6 to 75.5), and in Lugo 34.1/million (16.3 to 62.8). The incidence was greater in men than women for all groups except for Wegener's granulomatosis in Lugo, where there was female preponderance (table1).
We have previously reported the epidemiology of vasculitis in Norwich and Lugo5 6 using different methods. In this study we harmonised our methods and therefore could compare directly the incidence of PSV in our two populations. In both centres a single referral centre provides secondary care to its local population and this population can be easily identified. Referrals to outside hospitals are rare because both populations are relatively geographically isolated. Patients with PSV are sufficiently ill to be referred for secondary care and are therefore not managed in the community, by either general practitioners or private physicians. The data provide minimum estimates of the incidence of PSV in our communities. No significant change (although there was an upward trend) in incidence occurred during our study, suggesting that there were no major changes in the completeness of our data collection or referral patterns.
The overall incidence of PSV was similar in Norwich and Lugo, but there were trends towards differences in incidence for each condition. There was a greater incidence of WG in Norwich and MPA in Lugo. This supports the idea (suggested anecdotally by doctors interested in vasculitis) that WG is more common in the north, whereas MPA is more common in the south of Europe. CSS and PAN were both more common in Norwich. These differences reflect, we believe, genuine variations in incidence between populations rather than differences in classification or patient selection. By applying the same classification criteria/definitions to a defined population it is possible to identify differences in incidence between populations. For the reasons mentioned above we believe that our figures represent a population based incidence, but as with any epidemiology study we cannot be absolutely confident that we identified all patients.
The latitudinal trends in incidence for WG and MPA are supported by other studies. Koldingsnes from Tromso in North Norway reported a higher annual incidence of WG (15.0/million) than we did from the UK.7 In the south MPA is particularly common in Kuwait, with an annual incidence of 24/million.8 Methodological differences make it difficult to compare these populations directly with ours.
The aetiopathogenesis of PSV is unknown, but genetic and environmental factors are likely to be important. MPA and WG can sometimes be difficult to distinguish clinically and it has been suggested that they have a common pathogenesis. These data, however, point towards a difference in the pathogenesis of WG compared with MPA.
The age and sex distribution of the populations of Norwich and Lugo are broadly similar. Both populations are mainly Caucasoid, but there is a significant component of Celtic ancestry in Lugo. The HLA make up of the Lugo population differs from that found in other Mediterranean areas and has a similar proportion of HLA-DRB1 alleles to that in the UK population.9 No clear HLA association has been shown with any type of PSV,10 suggesting that environmental factors may be more important than genetic factors. There was a trend towards an increase in incidence in Norwich but not Lugo, suggesting that any environmental factors were probably unchanged during the period of the study. We were unable to find any evidence for cyclical changes in incidence as recently suggested in a retrospective hospital based study from Sweden.11 In the 1980s it was suggested that there was an increase in incidence of WG. This does not seem to have continued and was probably due to the introduction of routine antineutrophil cytoplasmic antibody testing and greater awareness of doctors.12
Further studies conducted in other parts of the world may yield interesting clues to the pathogenesis of these so far enigmatic diseases, and permit dissection of the interplay between genes and environment.
Dr Lane is supported by the Arthritis Research Campaign. We are grateful to the physicians of both hospitals for referring patients to us.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.